Current through the 2024 Fourth Special Session
Section 58-37f-203 - Submission, collection, and maintenance of data(1)(a) The division shall implement on a statewide basis, including non-resident pharmacies as defined in Section 58-17b-102, the following two options for a pharmacist to submit information: (i) real-time submission of the information required to be submitted under this part to the controlled substance database; and(ii) 24-hour daily or next business day, whichever is later, batch submission of the information required to be submitted under this part to the controlled substance database.(b) A pharmacist shall comply with either:(i) the submission time requirements established by the division under Subsection (1)(a)(i); or(ii) the submission time requirements established by the division under Subsection (1)(a)(ii).(c) Notwithstanding the time requirements described in Subsection (1)(a), a pharmacist may submit corrections to data that the pharmacist has submitted to the controlled substance database within seven business days after the day on which the division notifies the pharmacist that data is incomplete or corrections to the data are otherwise necessary.(d) The division shall comply with Title 63G, Chapter 6a, Utah Procurement Code.(2)(a) The pharmacist-in-charge and the pharmacist of the drug outlet where a controlled substance is dispensed shall submit the data described in this section to the division in accordance with:(i) the requirements of this section;(ii) the procedures established by the division;(iii) additional types of information or data fields established by the division; and(iv) the format established by the division.(b) A dispensing medical practitioner licensed under Chapter 17b, Part 8, Dispensing Medical Practitioner and Dispensing Medical Practitioner Clinic Pharmacy, shall comply with the provisions of this section and the dispensing medical practitioner shall assume the duties of the pharmacist under this chapter.(3)(a) Except as provided in Subsection (3)(b), the pharmacist-in-charge and the pharmacist described in Subsection (2)(a) shall, for each controlled substance dispensed by a pharmacist under the pharmacist's supervision, submit to the division any type of information or data field established by the division by rule in accordance with Subsection (6) regarding:(i) each controlled substance that is dispensed by the pharmacist or under the pharmacist's supervision; and(ii) each noncontrolled substance that is: (A) designated by the division under Subsection (8)(a); and(B) dispensed by the pharmacist or under the pharmacist's supervision.(b) Subsection (3)(a) does not apply to a drug that is dispensed for administration to, or use by, a patient at a health care facility, including a patient in an outpatient setting at the health care facility.(4) An individual whose records are in the database may obtain those records upon submission of a written request to the division.(5)(a) A patient whose record is in the database may contact the division in writing to request correction of any of the patient's database information that is incorrect.(b) The division shall grant or deny the request within 30 days from receipt of the request and shall advise the requesting patient of its decision within 35 days of receipt of the request.(c) If the division denies a request under this Subsection (5) or does not respond within 35 days, the patient may submit an appeal to the Department of Commerce, within 60 days after the patient's written request for a correction under this Subsection (5).(6) The division shall make rules, in accordance with Title 63G, Chapter 3, Utah Administrative Rulemaking Act, to establish submission requirements under this part, including: (b) submission procedures; and(c) required information and data fields.(7) The division shall ensure that the database system records and maintains for reference: (a) the identification of each individual who requests or receives information from the database;(b) the information provided to each individual; and(c) the date and time that the information is requested or provided.(8)(a) The division, in collaboration with the Utah Controlled Substance Advisory Committee created in Section 58-38a-201, shall designate a list of noncontrolled substances described in Subsection (8)(b) by rule made in accordance with Title 63G, Chapter 3, Utah Administrative Rulemaking Act.(b) To determine whether a prescription drug should be designated in the schedules of controlled substances under this chapter, the division may collect information about a prescription drug as defined in Section 58-17b-102 that is not designated in the schedules of controlled substances under this chapter.Amended by Chapter 340, 2021 General Session ,§ 8, eff. 5/5/2021.Amended by Chapter 372, 2020 General Session ,§ 17, eff. 5/12/2020.Amended by Chapter 339, 2020 General Session ,§ 48, eff. 5/12/2020.Amended by Chapter 147, 2020 General Session ,§ 1, eff. 5/12/2020.Amended by Chapter 59, 2019 General Session ,§ 3, eff. 7/1/2019.Amended by Chapter 59, 2019 General Session ,§ 2, eff. 5/14/2019.Amended by Chapter 1, 2018SP3 General Session ,§ 121, eff. 12/3/2018.Amended by Chapter 123, 2018 General Session ,§ 1, eff. 5/8/2018.Amended by Chapter 89, 2015 General Session ,§ 1, eff. 7/1/2015.Amended by Chapter 326, 2015 General Session ,§ 1, eff. 5/12/2015.Amended by Chapter 72, 2014 General Session ,§ 17, eff. 7/1/2014.Enacted by Chapter 287, 2010 General Session